Pfizer Discontinues Global Development of Bococizumab, Its Investigational PCSK9 Inhibitor
Go back to Pfizer Discontinues Global Development of Bococizumab, Its Investigational PCSK9 Inhibitor| Pfizer Inc. (NYSE: PFE) | Delayed: 24.82 +0.57 (2.35%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $24.25 | 52 Week High | $37.39 | |||
| Open | $24.34 | 52 Week Low | $28.25 | |||
| Day High | $24.82 | P/E | 15.04 | |||
| Day Low | $24.31 | EPS | $1.65 | |||
| Volume | 44,151,123 | |||||
